About
Humanized Monoclonal Antibody
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyBiotech
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
283
By Phase
PHASE1: 3PHASE2: 1PHASE1/PHASE2: 3
By Status
TERMINATED: 4ENROLLING_BY_INVITATION: 1RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06592768Lead Sponsor
A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma
PHASE1Terminated
17 participants
Started: Nov 26, 2024 · Completed: Aug 11, 2025
NCT06736262Lead Sponsor
A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials
PHASE2Enrolling by invitation
90 participants
Started: Nov 26, 2024 · Completed: Dec 1, 2026
NCT06353971Lead Sponsor
A Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- Antihistamines
PHASE1/PHASE2Terminated
27 participants
Started: Mar 18, 2024 · Completed: Jul 31, 2025
NCT06162728Lead Sponsor
Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Spontaneous Urticaria (CSU)
PHASE1/PHASE2Recruiting
80 participants
Started: Nov 29, 2023 · Completed: Apr 1, 2026
NCT05903274Lead Sponsor
JSP191 (briquilimab) in Subjects with LR-MDS
PHASE1Terminated
6 participants
Started: Jun 19, 2023 · Completed: Oct 21, 2024
Locations (1)
Headquarters
Redwood City, CA, United States
Map
Loading map...